Astellas Provides Update on Zolbetuximab Biologics License Application in U.S. | Antibodies

Retrieved on: 2024-01-09 15:19:16

Tags for this article:

Click the tags to see associated articles and topics

Astellas Provides Update on Zolbetuximab Biologics License Application in U.S. | Antibodies. View article details on hiswai:

Excerpt

Zolbetuximab is an investigational, first-in-class chimeric IgG1 monoclonal antibody (mAb) that targets and binds to claudin 18.2 (CLDN18.2), a ...

Article found on: pipelinereview.com